254 related articles for article (PubMed ID: 6804562)
1. Induction of anterior chamber-associated immune deviation (ACAID) by allogeneic intraocular tumors does not require splenic metastases.
Niederkorn JY; Streilein JW
J Immunol; 1982 Jun; 128(6):2470-4. PubMed ID: 6804562
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells.
Streilein JW; Niederkorn JY
J Immunol; 1985 Mar; 134(3):1381-7. PubMed ID: 3155766
[TBL] [Abstract][Full Text] [Related]
3. Intracamerally induced concomitant immunity: mice harboring progressively growing intraocular tumors are immune to spontaneous metastases and secondary tumor challenge.
Niederkorn JY; Streilein JW
J Immunol; 1983 Nov; 131(5):2587-94. PubMed ID: 6415174
[TBL] [Abstract][Full Text] [Related]
4. Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice.
Niederkorn J; Streilein JW; Shadduck JA
Invest Ophthalmol Vis Sci; 1981 Mar; 20(3):355-63. PubMed ID: 6782034
[TBL] [Abstract][Full Text] [Related]
5. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses.
Niederkorn JY; Streilein JW
J Immunol; 1983 Dec; 131(6):2670-4. PubMed ID: 6196396
[TBL] [Abstract][Full Text] [Related]
6. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space.
Wenkel H; Chen PW; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3202-8. PubMed ID: 10586943
[TBL] [Abstract][Full Text] [Related]
7. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type.
Hara Y; Okamoto S; Rouse B; Streilein JW
J Immunol; 1993 Nov; 151(10):5162-71. PubMed ID: 8228216
[TBL] [Abstract][Full Text] [Related]
8. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood.
Wilbanks GA; Streilein JW
J Immunol; 1991 Apr; 146(8):2610-7. PubMed ID: 1707912
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 abrogates anterior chamber-associated immune deviation.
Benson JL; Niederkorn JY
Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):2123-8. PubMed ID: 1698740
[TBL] [Abstract][Full Text] [Related]
10. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta.
Wilbanks GA; Mammolenti M; Streilein JW
Eur J Immunol; 1992 Jan; 22(1):165-73. PubMed ID: 1530916
[TBL] [Abstract][Full Text] [Related]
11. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
[TBL] [Abstract][Full Text] [Related]
12. Blood-borne signals that induce anterior chamber-associated immune deviation after intracameral injection of antigen.
Streilein JW; Okamoto S; Hara Y; Kosiewicz M; Ksander B
Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2245-54. PubMed ID: 9344347
[TBL] [Abstract][Full Text] [Related]
13. Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID.
Wilbanks GA; Mammolenti M; Streilein JW
J Immunol; 1991 May; 146(9):3018-24. PubMed ID: 2016537
[TBL] [Abstract][Full Text] [Related]
14. Analysis of an in vitro-generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye.
Hara Y; Caspi RR; Wiggert B; Dorf M; Streilein JW
J Immunol; 1992 Sep; 149(5):1531-8. PubMed ID: 1387141
[TBL] [Abstract][Full Text] [Related]
15. Adoptive transfer of immunity to intraocular tumors in mice.
Niederkorn JY; Streilein JW
Invest Ophthalmol Vis Sci; 1984 Mar; 25(3):336-42. PubMed ID: 6421767
[TBL] [Abstract][Full Text] [Related]
16. Role of splenic B cells in the immune privilege of the anterior chamber of the eye.
Niederkorn JY; Mayhew E
Eur J Immunol; 1995 Oct; 25(10):2783-7. PubMed ID: 7589072
[TBL] [Abstract][Full Text] [Related]
17. Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells.
Chattopadhyay S; O'Rourke J; Cone RE
Int Immunol; 2008 Apr; 20(4):509-16. PubMed ID: 18359787
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
Yamada J; Zhu SN; Streilein JW; Dana MR
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
[TBL] [Abstract][Full Text] [Related]
19. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen.
Streilein JW; Niederkorn JY
J Exp Med; 1981 May; 153(5):1058-67. PubMed ID: 6788883
[TBL] [Abstract][Full Text] [Related]
20. The immune response and the eye: the ACAID inducing signal is dependent on the nature of the antigen.
Ferguson TA; Herndon JM
Invest Ophthalmol Vis Sci; 1994 Jun; 35(7):3085-93. PubMed ID: 8206727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
